Anti-CD38 plus corticosteroids plus a non-corticosteroid chemotherapeutic for treating tumors

Details for Australian Patent Application No. 2007302448 (hide)

Owner Genmab A/S

Inventors Graus, Yvo; Winkel, Jan van de; Weers, Michel de; Parren, Paul; Vugt, Martine van; Baadsgaard, Ole; Lisby, Steen; Oprins, Judith

Agent Watermark

Pub. Number AU-A-2007302448

PCT Pub. Number WO2008/037257

Priority PA 2006 01232 26.09.06 DK; 60/847,329 26.09.06 US

Filing date 26 September 2007

Wipo publication date 3 April 2008

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 31/573 (2006.01)

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/037257 Priority application(s): WO2008/037257

25 June 2009 Amendment Made

  The nature of the amendment is: Amend the invention title to read Combination treatment of CD38-expressing tumors

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007302449-[2-(6-flouro-1H-indol-3-ylsulfanyl)benzyl ]methyl amine for the treatment of affective disorders

2007302446-Alkali resistant catalyst